Kuwait and Middle East Financial Investment Company K.S.C.P. (KWSE:KMEFIC)

Ligand Pharmaceuticals Cash Flow Statement

Financials in millions KWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	4.4	3.36	-5.37	1.04	3.1	7.86
Depreciation & Amortization	0.22	0.4	0.31	0.61	0.18	0.03
Other Amortization	-	-	-	0.03	0.04	0.12
Loss (Gain) From Sale of Assets	-0.01	-	-0.01	-	-	-
Asset Writedown & Restructuring Costs	-0.84	-0.84	0.46	-3.94	-	-9
Loss (Gain) From Sale of Investments	-6.5	-2.21	5.06	3.51	-0.76	1.54
Other Operating Activities	5.43	1.89	1.46	1.57	-0.17	0.11
Change in Accounts Payable	0.65	-0.19	0.29	2.04	-1.26	2.84
Change in Other Net Operating Assets	-1.93	-0.52	1.88	0	-3.18	-1.84
Operating Cash Flow	7.05	2.5	1.19	-20.92	-0.51	0.58
Operating Cash Flow Growth	169.95%	110.92%	-	-	-	258.69%
Capital Expenditures	0.23	-0.05	-0.05	-1.09	-0.58	-0.07
Sale of Property, Plant & Equipment	-	-	0.01	-	-	-
Sale (Purchase) of Real Estate	-0.73	-6.28	-	-15.87	-2.24	5.5
Investment in Securities	0.75	-0.31	1.2	1.35	-1.98	-0.81
Other Investing Activities	0.63	0.63	0.65	0.01	-0.58	0.01
Investing Cash Flow	0.88	-6.01	1.82	-15.6	-5.38	4.63
Long-Term Debt Issued	-	7.64	1.27	40.11	4.73	-
Long-Term Debt Repaid	-	-1.99	-2.85	-1.58	-0.19	-
Net Debt Issued (Repaid)	-3.53	5.65	-1.58	38.54	4.54	-
Repurchase of Common Stock	-	-	-	-	-1.64	-0.01
Common Dividends Paid	-	-	-0	-1.53	-	-
Other Financing Activities	-3.39	-3.32	-2.17	0.59	-0.04	-0.89
Financing Cash Flow	-6.92	2.33	-3.75	37.6	2.86	-0.9
Net Cash Flow	1.01	-1.18	-0.75	1.08	-3.03	4.31
Free Cash Flow	7.28	2.45	1.14	-22.01	-1.09	0.51
Free Cash Flow Growth	207.31%	115.12%	-	-	-	608.09%
Free Cash Flow Margin	54.73%	28.73%	307.42%	-790.38%	-17.34%	29.15%
Free Cash Flow Per Share	0.03	0.01	0.01	-0.10	-0.01	0.00
Cash Interest Paid	2.82	3.26	2.17	0.36	0.04	-
Cash Income Tax Paid	0	0.06	0.11	0.09	0.29	0.06
Levered Free Cash Flow	3.63	1.26	0.26	-0.6	-3.66	-2.58
Unlevered Free Cash Flow	5.43	3.01	1.86	0.02	-3.63	-2.58
Change in Working Capital	4.22	-0.19	-0.82	-23.74	-2.92	-0.09

Updated Nov 17, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.